Using ECT in schizophrenia: A review from a clinical perspective

World Journal of Biological Psychiatry

Volumn 13, Issue 2, 2012, Pages 96-105

  Zervas, Iannis M ^a   Theleritis, Christos ^a   Soldatos, Costantin R ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

ECT; Electroconvulsive therapy; Psychopharmacology; Psychosis; Schizophrenia

Indexed keywords

CLOZAPINE; FLUPENTIXOL; LORAZEPAM; NEUROLEPTIC AGENT;

AFFECTIVE NEUROSIS; CATATONIC SCHIZOPHRENIA; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTRODE; ELECTROSTIMULATION; HUMAN; MEDLINE; MEMORY DISORDER; NEUROLEPTIC MALIGNANT SYNDROME; NONHUMAN; PARANOIA; POSITIVE SYNDROME; REVIEW; SCHIZOPHRENIA; SYMPTOM; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ANTIPSYCHOTIC AGENTS; CATATONIA; CLOZAPINE; COMBINED MODALITY THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; SCHIZOPHRENIA;

EID: 84856741368     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.564653     Document Type: Review

References (79)

1. Abraham KR, Kulhara P. 1987. The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study. Br J Psychiatry 151:152-155. (Pubitemid 17102087)
2. American Psychiatric Association. 1990. The practice of ECT: Recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Press.
3. American Psychiatric Association. 2001. Committee on Electro-convulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training and privileging: a task force report of the American Psychiatric Association. 2nd ed. Washington DC: American Psychiatric Association.
4. Agarwal AK, Winny GC. 1985. Role of ECT-phenothiazine combination in schizophrenia. Indian J Psychiatry 27:233-236.
5. Andrade C. 2004. Electroconvulsive therapy in schizophrenia. In: Mandal MK, Haque-Nizamie S, eds. Schizophrenia. New Delhi: Allied Publishers. p. 272-303.
6. Andrade C, Kurinji S. 2002. Continuation and maintenance ECT: a review of recent research. J ECT 18:149-158. (Pubitemid 35192429)
7. Bagadia VN, Shah LP, Pradhan PV, Doshi J, Abhyankar RR. 1981. Evaluation of cognitive effects of ECT: preliminary observations. Indian Journal Psychiatry 23(4):324-329. (Pubitemid 12000335)
8. Bagadia VN, Abhyankar R, Pradhan PV, Shah LP. 1988. Reevalu-ation of ECT in schizophrenia: right temporoparietal versus bitemporal electrode placement. Convuls Ther 4:215-220.
9. Baghai TC, Möller H-J. 2008. Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci 10:105-117. (Pubitemid 351542982)
10. Baker A, Bird G, Lavin N, Thorpe J. 1960. ECT in schizophrenia. J Ment Sci 106:1506-1511.
11. Braga RJ, Petrides G. 2005. The combined use of electroconvul-sive therapy and antipsychotics in patients with schizophrenia. J ECT 21:75-83. (Pubitemid 40800031)
12. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S. 1984. Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. Br Med J 288:22-25. (Pubitemid 14115329)
13. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S. 1985. Leicester ECT trial: results in schizophrenia. Br J Psychiatry 146:177-183. (Pubitemid 15162124)
14. Bush G, Fink M, Petrides G, Dowling F, Francis A. 1996. Cata-tonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93(2):137-143. (Pubitemid 26084531)
15. Cerletti U, Bini L. 1938. L̀ Elettroshock. Arch Gen Neurol Psichi-atr Psicoanal 19:226.
16. Chanpattana W. 1999. ECT in schizophrenia. J Psychiatr Assoc Thai 44:156-170.
17. Chanpattana W. 2000. Maintenance ECT in medication-resistant schizophrenia. J Med Assoc Thai 83:657-662.
18. Chanpattana W, Andrade C. 2006. ECT for treatment-resistant schizophrenia: A response from the Far East to the UK NICE Report. J ECT 22:4-12. (Pubitemid 44491123)
19. Chanpattana W, Chakrabhand MLS. 2001a. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res 105:107-115. (Pubitemid 34015888)
20. Chanpattana W, Chakrabhand MLS. 2001b. Factors influencing treatment frequency of continuation ECT in schizophrenia. J ECT 17:190-194. (Pubitemid 32831375)
21. Chanpattana W, Kramer BA. 2003. Acute and maintenance ECT with flupentixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res 63:189-193. (Pubitemid 36929860)
22. Chanpattana W, Sackeim HA. 2010. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement. J ECT 26(4): 289-98.
23. Chanpattana W, Kitaroonchai W, Prasertsuk Y, Chakrabhand MLS, Choovanichvong S. 1999a. Effects of twice versus thrice weekly electroconvulsive therapy in schizophrenia. J Med Assoc Thai 82: 477-82.
24. ChanpattanaW, Chakrabhand ML, Sackeim HA, Kitaroonchai W, Kongsakon R, Techakasem P, et al. 1999b. Continuation ECT in treatment resistant schizophrenia: a controlled study. J ECT 15:178-192.
25. Chanpattana W, Chakrabhand ML, Kirdcharoen N, Tuntirungsee Y, Techakasem P, Prasertsuk Y. 1999c. The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation. J Med Assoc Thai 82:558-568.
26. Chanpattana W, Chakrabhand ML, Buppanharun W, Sackeim HA. 2000. Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry 48:222-228. (Pubitemid 30618994)
27. Conley RR, Buchanan RW. 1997. Evaluation of treatment-resistant schizophrenia. Schizophr Bull 23:663-674. (Pubitemid 27485974)
28. Croarkin PE, Emslie GJ, Mayes TL. 2008. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry 69(7): 1157-1165. (Pubitemid 352031600)
29. Doongaji D, Jeste D, Saoji N, Kane P, Ravindranath S. 1973. Unilateral versus bilateral ECT in schizophrenia. Br J Psychiatry 123:73-79.
30. el-Islam MF, Ahmed S, Erfan M. 1970. The effect of unilateral ECT on schizophrenic delusions and hallucinations. Br J Psychiatry 117:447-448.
31. Fink M. 2001. ECT has much to offer our patients: it should not be ignored. World J Biol Psychiatry 2:1-8.
32. Fink M, Taylor MA. 2009. The catatonia syndrome: Forgotten but not gone. Arch Gen Psychiatry 66:1173-1177.
33. Fink M, Sackeim. 1996 Convulsive therapy in scizophrenia? Schizophr Bull 22:27-39.
34. Goswami U, Kumar U, Singh B. 2003. Efficacy of electroconvul-sive therapy in treatment-resistant schizophrenia: a double-blind study. Indian J Psychiatry 45:26-29. (Pubitemid 36657671)
35. Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. 2005. Clinical and cost effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. Health Technol Assess 9:1-156.
36. Havaki-Kontaxaki BJ, Ferentinos PP, Kontaxakis VP, Paplos KG, Soldatos CR. 2006. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia. Clin Neuropharmacol 29:52-56. (Pubitemid 44378611)
37. Haskett RF, Loo C. 2010. Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia. J ECT 26(3):196-201.
38. Hatta K, Miyakawa K, Ota T, Usui C, Nakamura H, Arai H. 2007. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT 23(4):213-214.
39. Herzberg F. 1954. Prognostic variables for electro-shock therapy. J Gen Psychol 50:79-86.
40. Hustig H, Onilov R. 2009. ECT rekindles pharmacological response in schizophrenia. Eur Psychiatry 24:521-525.
41. Johns CA, Thompson JW. 1995. Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophr Bull 21:607-619.
42. Kalinowsky LB, Worthing H. 1943. Results with electric convulsive therapy in 200 cases of schizophrenia. Psychiatr Q 17:144-153.
43. Kane JM. 1999. Management strategies for the treatment of schizophrenia. J Clin Psychiatry 60(Suppl 12):13-17. (Pubitemid 29283176)
44. Kellner CH, Knapp R, Hussain MM, Rasmussen K, Sampson S, Kullum M, et al. 2010. Bifrontal, bilateral and right unilateral electrode placemtent in ECT: randomized trial. Br J Psychiatry 196:226-234.
45. Kristensen D, Bauer J, Hageman I, J ø rgensen MB. 2010. Electro-convulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Eur Arch Psychiatry Clin Neurosci (Epub ahead of print Dec 5 2010).
46. Kramer BA. 1987. Maintenance ECT: a survey of practice. Convuls Ther 3:260-268.
47. Kuwahara T, Yoshino A, Horikawa N, Nomura S. 2009. Delayed sympathetic hyperactivity following electroconvulsive therapy in patients with catatonic schizophrenia. Nihon Shinkei Seishin Yakurigaku Zasshi 29:79-83.
48. Lerer B, Shapira B, Calev A, Tubi N, Drexler H, Kindler S, et al. 1995. Antidepressant and cognitive effects of twice, versus three-times-weekly ECT. Am J Psychiatry 152:564-570.
49. Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I. 2008. Maintenance electroconvulsive therapy and treatment of refractory schizophrenia. Encephale 34:526-533.
50. Lykouras L, Avgoustides D, Papakostas Y, Stefanis C. 1995. Medication response to ECT-resistant melancholic patients. Acta Psychiatr Belg 95:113-121.
51. Matheson SL, Green MJ, Loo C, Carr VJ. 2010. Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizo phrenia: a systematic meta-review. Schizophr Res 118(1-3):201-210.
52. McCall WV. 2001. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 4: 315-324. (Pubitemid 34103004)
53. Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles J, Conley RR, et al. 2004. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry 65:500-508.
54. Moore MP. 1943. The maintenance treatment of chronic psy chotics by electrically induced convulsions. J Ment Sci 89: 257-269.
55. National Institute for Clinical Excellence. 2003. Guidance on the use of electroconvulsive therapy. NICE Technology Appraisal Guidance 59. London: National Institute for Clinical Excellence.
56. Nothdurfter C, Eser D, Schule C, Zwanzger P, Marcuse A, Noack I, et al. 2006. The influence of concomittant neuroleptic medication on safety, tolerability and Clinical effectiveness of ECT. World J Biol Psychiatry 7: 162-170. (Pubitemid 44132542)
57. Painuli N, Chakrabarti S. 2006. Combined use of electroconvul-sive therapy and antipsychotics in schizophrenia: The Indian evidence. A review and meta-analysis. J ECT 22:59-66. (Pubitemid 44491134)
58. Petrides G. 1998. Continuation ECT: a review. Psychiatr Ann 28:517-523. (Pubitemid 128626876)
59. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. 2003. Patients ' perspectives on electroconvulsive therapy: systematic review. Br Med J 326:1363-1365. (Pubitemid 36751033)
60. Royal College of Psychiatrists. 1995. The ECT Handbook: The Second Report of the Royal College of Psychiatrists ' Special Committee on ECT. London: Royal College of Psychiatrists.
61. Sackeim HA. 2003. Electroconvulsive therapy for schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. 2nd ed. Blackwell: Oxford. p 517-551.
62. Sackeim HA, Prudic J, Devanand DP, Kierskey JE, Fitzsimons L, Moody BJ, et al. 1993. Effects of stimulus intensity and electrode placement on the efficay and cognitive effects of electro-convulsive therapy. New Engl J Med 328:839-846. (Pubitemid 23084338)
63. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, et al. 2000. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57:425-434. (Pubitemid 30257256)
64. Salzman C. 1998. ECT, research, and professional ambivalence. Am J Psychiatry 155:1-2. (Pubitemid 28037540)
65. Sarita EP, Janakiramiah N, Ganagadhar BN, Subbakrishna DK, Rao KMJ. 1998. Efficacy of combined ECT after two weeks of neuroleptics in schizophrenia: A double blind controlled study. NIMHANS J 16:243-251.
66. Shapira B, Tubi N, Drexler H, Lidsky D, Calev A, Lerer B. 1998. Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT. Br J Psychiatry 172:44-48. (Pubitemid 28122526)
67. Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H. 2005. Continuation electroconvulsive therapy for relapse prevention in middle aged and elderly patients with intractable catatonic schizophrenia. Psychiatry Clin Neurosci 59:481-489. (Pubitemid 41139558)
68. Swoboda E, Conca A, Konig P, Waanders R, Hansen M. 2001. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43:23-28. (Pubitemid 32041418)
69. Taylor P. 1981. ECT and schizophrenia in Great Britain. Am J Psychiatry 132:259-260.
70. Taylor PJ, Fleminger JJ. 1980. ECT for schizophrenia. Lancet i:1380-1382.
71. Tharyan P, Adams CE. 2008. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev Issue 3.
72. Thirthalli J, Kumar CN, Bangalore RP, Gangadhar BN. 2009. Speed of response to threshold and suprathreshold bilateral ECT in depression, mania and schizophrenia. J Affect Disord 117:104-107.
73. Trollor JN, Sachdev PS. 1999. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 33(5):650-659. (Pubitemid 29488160)
74. Wessels WH. 1972. A comparative study of the efficacy of bilateral and unilateral electroconvulsive therapy with thioridazine in acute schizophrenia. S Afr Med J 46:890-892.
75. Witton K. 1962. Efficacy of ECT following prolonged use of psychotropic drugs. Am J Psychiatry 119:79.
76. Wittman P. 1941. A scale for measuring prognosis in schizophrenic patients. Elgin Pap 4:20-33.
77. World Health Organization. 1979. Schizophrenia: An international follow-up study. New York: Wiley.
78. Wu D, She CW, Liu CZ, Cho WL, Quon M, Liu SY, Ai SC. 1989. Using BPRS and serial numbers and picture recall to test the effectiveness of ECT versus chlorpromazine versus chlorpromazine alone in the treatment of schizophrenia: 40 cases, single blind observations. Chin J Nerv Ment Disord 15: 26-28.
79. Zervas IM, Greenberg LB, Suckow RF, Cooper T, Jandorf L, Fink M. 1990. The rat brain concentration of fluphenazine during a course of electroconvulsive shock. Convuls Ther 6: 273-278.